Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 12, 2011

Premium

Bassem Bejjani has left Signature Genomics. With Lisa Shaffer, Bejjani co-founded Signature in 2003 and most recently served as the company's chief medical officer. Prior to his tenure at Signature, he was an associate director of the Kleberg Cytogenetics Laboratory at Baylor College of Medicine.

PerkinElmer acquired Spokane, Wash.-based Signature last year (BAN 4/20/2011).


23andMe has appointed Ashley Dombkowski to be its chief business officer, where she will be responsible for the firm's translational collaboration initiatives. Dombkowski, who was previously a member of the company's board of directors, spent 10 years at MPM Capital as managing director and was also a healthcare analyst at Tiger Management and Dresdner RCM Global Investors.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.